GIC purchases minority stake in Envu
Cinven will remain the majority investor in the company. read more
Cinven will remain the majority investor in the company. read more
Envu’s decarbonization pathway highlights significant reductions in operational emissions and expanded engagement with suppliers. read more
The distinguished certification is awarded based on employee feedback around three key factors: trust, pride and camaraderie. read more
Tarvecta works on multiple difficult diseases as a combination of two important active ingredients, fluoxastrobin and flutriafol. read more